BPL Vivid Vue 12i Patient Monitor | ICU Multipara Monitor

BPL Vivid Vue 12i Patient Monitor | ICU Multipara Monitor

Marsoni

M251S

$54100.00

Get it in 3 business days with 1 day shipping. Friday, May 29

BPL Vivid Vue 12i Patient Monitor | ICU Multipara MonitorMultipara Monitor Advanced patient tracking SPO2 Accuracy Reliable oxygen monitoring Instant Alerts Real time alarm system ICU Ready Critical care support The BPL patient monitor Vivid Vue 12i is a high performance multipara monitor designed for ICU monitor machine environments. It continuously tracks vital parameters such as ECG, SPO2, NIBP, respiration, and temperature. As a result, it ensures precise real time monitoring and enhances patient safety

Easy Shipping

Quick Dispatch:

Your BPL Vivid Vue 12i Patient Monitor | ICU Multipara Monitor orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your BPL Vivid Vue 12i Patient Monitor | ICU Multipara Monitor ships.

Need Help?
Questions about BPL Vivid Vue 12i Patient Monitor | ICU Multipara Monitor, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for BPL Vivid Vue 12i Patient Monitor | ICU Multipara Monitor in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Cheap but pretty tuff. No it isn't my old tried and true Timex but is does wear well and servives even at work. I pack a lot of material in my hands all day and no watch goes without scratching but this watch has taken it so far. No time loss and the date stays curent so no complaints from me about it.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 26, 2026